169750-17-8Relevant articles and documents
Halogen-substituted latrotinib compound
-
Paragraph 0060; 0063-0064; 0076-0081, (2021/02/10)
The invention relates to a halogen-substituted latrotinib compound. The halogen-substituted latrotinib compound comprises a latrotinib bisulfate compound labeled by a radioactive halogen atom or a non-radioactive halogen atom. The compound comprises a (R,
KRAS G12C INHIBITORS
-
Paragraph 0247-0248, (2020/03/23)
The present invention relates to compounds that, inhibit KRas G12C, In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
A fluorine-substituted pyrrolidinium-based ionic liquid for high-voltage Li-ion batteries
Dzwiniel, Trevor L.,Hsu, Chia-Wei,Liu, Qian,Pupek, Krzysztof Z.,Zhang, Zhengcheng
supporting information, p. 7317 - 7320 (2020/07/14)
A fluorine-substituted ionic liquid based on a pyrrolidinium cation and a bis(fluorosulfonyl)imide anion was synthesized using a facile one-step reaction. The resulting ionic liquid is highly pure and when dissolved with LiFSI, the IL-based electrolyte sh